Advertisement
Journal Home
Search for

Volume 90, Issue 1, Pages 25-30 (January 2010)


View previous. 6 of 12 View next.

Identification of promoter-binding proteins of the fbp A and C genes in Mycobacterium tuberculosis

Ibeth C. RomeroaCorresponding Author Informationemail address, Carolina Mehaffybemail address, Richard J. Burchmorecemail address, Karen Dobos-Elderbemail address, Patrick Brennanbemail address, John Walkerademail addressemail address

Received 11 March 2009; received in revised form 27 August 2009; accepted 5 October 2009. published online 04 December 2009.

Summary 

The antigen 85 (Ag85) complex of Mycobacterium tuberculosis represents a promising candidate as a novel drug target and pathogenesis factor. Ag85 comprises three proteins Ag85A, B and C, (encoded by the genes fbpA, B, and C), which participate in cell wall biosynthesis, and interact with the host macrophage as fibronectin-binding proteins (fbps). Ag85 is also involved in the response to isoniazid (INH) treatment. The objective of this study was to identify potential fbp gene activators involved in the over-expression of fbp genes in response to INH.

The biotinylated upstream promoter regions of fbpA and fbpC were used together with streptavidin-coated magnetic beads in DNA-binding assays, to isolate proteins with high-binding affinities from cytosolic extracts of INH-treated M. tuberculosis. Resolution of the DNA-binding proteins by 1D SDS-PAGE revealed 6 proteins with high-affinity for the fbpA promoter, and 7 with specificity the fbpC promoter. Mass spectrometric analyses [LC-ES(MS/MS)] identified proteins associated with drug resistance and stress/treatment responses, intermediary metabolism and cellular division, hypothetical proteins including a member of the MarR family of bacterial transcriptional regulators. The DNA-binding MarR protein shows potential as an authentic activator of fbp genes and functional validation of this factor is warranted.

a Centro Internacional de Entrenamiento e Investigaciones Medicas (CIDEIM), Centro Colombiano de Investigacion en Tuberculosis CCITB, Kra. 125 No. 19-225 Pance, Cali, Colombia

b Department of Microbiology, Immunology and Pathology, Colorado State University (CSU), Fort Collins, CO 80523, USA

c Sir Henry Wellcome Functional Genomics Facility, Institute of Biochemical and Life Sciences, Division of Infection and Immunity, University of Glasgow, Glasgow G12_8QQ, UK

Corresponding Author InformationCorresponding author. Tel.: +57 (2) 555 2164; fax: +57 (2) 555 2638.

d Present address: Department of Biology, Forensics and Sport, Faculty of Education, Health and Science, University of Derby, Kedleston Road, Derby, DE22 IGB, UK.

PII: S1472-9792(09)00087-0

doi:10.1016/j.tube.2009.10.001


View previous. 6 of 12 View next.

Advertisement